Carlo Baldassarre Federici
Government, Health and Not for Profit
Biography
Carlo Federici is a Researcher in Health Economics and Health Technology Assessment (HTA) at the Research Center for the Management of Sociosanitary Care (CERGAS) at SDA Bocconi School of Management.
At SDA Bocconi, Carlo teaches the Advanced Decision Modelling course in the international Master's program MIHMEP (Master of International Healthcare Management, Economics, and Policy) and various courses on HTA and economic evaluation of healthcare technologies.
Carlo has contributed to several European projects, including the H2020 COMED projects focused on the evaluation of medical devices; the Horizon Europe Sagittarius project on the clinical and economic evaluation of new prognostic tests for patients with colorectal cancer; the Sustain-HTA project on the creation of a European infrastructure for the dissemination of HTA; and the HEU-EFS project on defining a European framework for conducting early-feasibility studies for medical devices. In recent years, Carlo has also been involved in research activities with the Italian Ministry of Health, focusing on reimbursement processes and regulatory aspects of new technologies.
His research activities primarily focus on HTA and the evaluation of health policies, with a focus on both methodological aspects and empirical applications using analytical decision models to estimate the cost-effectiveness of innovative technologies compared to other policy alternatives. Other recent research areas include projects in the field of Global Health, such as an economic evaluation of digital health interventions in vaccination programs in sub-Saharan Africa and Latin America or the impact assessment of a training program to promote an integrated approach in ante- and post-natal care services in Kenya.
Carlo is the author of numerous articles on these topics, published in journals such as Value in Health, PlosOne, Pharmacoeconomics, and Health Policy. He serves as an editor for the pharmacoeconomics and clinical outcomes section of the journal Clinical Therapeutics. He is a member of the Italian Health Economics Association (AIES) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Carlo earned an MSc in Health Economics from the University of York and a Ph.D. from the University of Warwick.
Teaching domains
Markov Models
Economic Evaluations of Drugs
Meta-Analysis
Survival Analysis
Statistics for Clinical Studies
Latest publications
Esiti di salute e performance del Servizio Sanitario Nazionale in Rapporto OASI 2023
CERGAS (Eds),Egea, chap. 7, pp.267-316, 2023
Cost-effectiveness Analysis of Radiofrequency Ablation in Patients With Barrett Esophagus and High-grade Dysplasia or Low-grade Dysplasia
Clinical Therapeutics, 2023, vol.45, no. 5, pp.426-436
I dati amministrativi per la governance dei tempi di attesa delle prestazioni ambulatoriali: l’esperienza dell’Azienda Sanitaria dell’Alto Adige
Mecosan, 2023, no. 123, pp.53-75
Esiti di salute e performance del Servizio Sanitario Nazionale in Rapporto OASI 2022
CERGAS (Eds),Egea, chap. 7, pp.285-346, 2022
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome
European Journal of Hospital Pharmacy, 2022, vol.29, no. 6, pp.346-352
Use of Resource Modeling to Quantify the Organizational Impact of Subcutaneous Formulations for the Treatment of Oncologic Patients: The Case of Daratumumab in Multiple Myeloma
Clinical Therapeutics, 2022, vol.44, no. 11, pp.1480-1493
